Catriona Yale, Chief Development Officer: Akero Therapeutics AKRO Sell · Filed 25/06/20

Trade details

Type: Insider sale
Amount: $89,553.72
Shares · price: 1,633 sh · $54.84 a share
Held after: 90,598 sh
Stock: Akero Therapeutics AKRO
Person: Catriona YaleChief Development Officer
Trade date: 25/06/18
Filed: 25/06/20
Days to filing: 2 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/19~25/07/18

Catriona Yale's recent trades

Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$28.4K
659 sh
$28.4K
Filed 25/09/12
Traded 25/09/11
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$457.7K
8,658 sh
$457.7K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$71.8K
1,342 sh
$71.8K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$334K
6,210 sh
$334K
Filed 25/06/20
Traded 25/06/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$158.6K
2,895 sh
$158.6K
Filed 25/06/20
Traded 25/06/16